Donnenfeld A E, Librizzi R J, Dunn L K, Craparo F, Godmilow L, Weiner S
Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia 19107.
Am J Med Genet. 1993 Feb 1;45(3):361-4. doi: 10.1002/ajmg.1320450316.
In our consecutive series of 2,574 chorionic villus sampling (CVS) patients, 146 women (5.7%) underwent a subsequent amniocentesis in the same pregnancy for the indications of absent or insufficient villi (3.3%), elevated maternal serum alpha-fetoprotein (0.93%), CVS mosaicism (0.89%), culture failure (0.23%), specimen contamination (0.15%), and CVS aneuploidy (0.12%). Patients presenting for a CVS should be informed of the possible need for a subsequent amniocentesis in the same pregnancy. There is a need for individual prenatal diagnosis programs to analyze their own data and provide genetic counseling information which pertains specifically to their institution.
在我们连续纳入的2574例绒毛取样(CVS)患者中,146名女性(5.7%)在同一孕期因绒毛缺乏或不足(3.3%)、孕妇血清甲胎蛋白升高(0.93%)、CVS嵌合体(0.89%)、培养失败(0.23%)、样本污染(0.15%)以及CVS非整倍体(0.12%)等指征而接受了后续羊水穿刺。接受CVS检查的患者应被告知在同一孕期可能需要进行后续羊水穿刺。各产前诊断项目需要分析自身数据,并提供专门适用于其机构的遗传咨询信息。